Dominant effector genetics in mammalian cells

Nature Genetics

Volumn 27, Issue 1, 2001, Pages 23-29

  Xu, Xiang ^a   Leo, Cindy ^a   Jang, Yngju ^a   Chan, Eva ^a   Padilla, David ^a   Huang, Betty C B ^a   Lin, Tong ^a   Gururaja, Tarikere ^a   Hitoshi, Yasumichi ^a   Lorens, James B ^a   Anderson, David C ^a   Sikic, Branimir ^b   Luo, Ying ^a   Payan, Donald G ^a   Nolan, Garry P ^b  

^a RIGEL PHARMACEUTICALS INC   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PEPTIDE LIBRARY; PROTEASOME; RHODAMINE 123; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; GENE EXPRESSION REGULATION; HELA CELL; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TUMOR CELL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL DEATH; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; GENES, MDR; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; PACLITAXEL; PEPTIDE LIBRARY; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN SUBUNITS; RNA, MESSENGER; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION;

ANIMALIA; MAMMALIA;

EID: 0035158568     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/83717     Document Type: Article

References (47)

1. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery
2. Combinatorial chemistry: Polymer supported synthesis of peptide and non-peptide libraries
3. Ribosome display: An in vitro method for selection and evolution of antibodies from libraries
4. The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries
5. Isolation of peptide aptamers that inhibit intracellular processes
6. Genetic selection of peptide inhibitors of biological pathways
7. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
8. Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization
9. Identification of p53 genetic suppressor elements which confer resistance to cisplatin
10. Multidrug resistance: Clinical relevance in solid tumours and strategies for circumvention
11. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia
12. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells
13. Expression and function of P-glycoprotein in human mesangial cells
14. The physiological function of drug-transporting P-glycoproteins
15. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
16. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin
17. Multidrug resistance and its reversal
18. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
19. Multidrug resistance in leukemia
20. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells
21. Selective proteasome inhibitors: Modulators of antigen presentation?
22. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator
23. Signal-induced site-specific phosphorylation targets I κ 8 α to the ubiquitin-proteasome pathway
24. Degradation mechanism of cell cycle factors by the proteasome
25. Proteasome inhibitors: Valuable new tools for cell biologists
26. Transactivation of the human MDR1 gene by hepatitis 8 virus X gene product
27. Proteasome complex as a potential cellular target of hepatitis B virus X protein
28. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex
29. Inhibition of ubiquitin-proteasome pathway-mediated I κ 8 α degradation by a naturally occurring antibacterial peptide
30. Proteasome subunit ζ a putative ribonuclease, is also found as a free monomer
31. Involvement of proteasomal subunits ζ and ι in RNA degradation
32. Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells
33. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress
34. Proteasome inhibition leads to the activation of all members of the heat-shock-factor family
35. Transdominant genetic analysis of a growth control pathway
36. An anti-CD3O single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line
37. High-affinity peptide ligands for pancreatic α-amylase by phage display
38. Small peptides as potent mimetics of the protein hormone erythropoietin
39. Retroviral delivery of peptide modulators of cellular functions
40. A novel artificial loop scaffold for the non-covalent constraint of peptides
41. Production of high-titer helper-free retroviruses by transient transfection
42. The neuropeptide head activator loses its biological activity by dimerization
43. Transfection of DNA into eukaryotic cells
44. Toso, cell surface, specific regulator of Fas-induced apoptosis in T cells
45. Peptide coupling reagents. N-[Oxytris(dimethylamino)phosphonium]benzotriazole hexafluorophosphate
46. Solid-phase synthesis and characterization of human salivary statherin: A tyrosine-rich phosphoprotein inhibitor of calcium phosphate precipitation
47. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein G, altered phenotype, resistance to cyclosporins